Shopping Cart 0
Cart Subtotal
AED 0

Global Transplant Diagnostics Market Information, Product & Service (Instruments, Reagents & Consumables), Screening Type (Pre-Transplant, Post-Transplant), Organ Type (Kidney, Liver, Heart, Lung, Pancreas), Application Type, End-User - Forecast to 2023

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 16332

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 22938

Details

Introduction

Transplant diagnostic is a test which is performed during organ transplantation to identify the compatibility of the organ. It is a medical procedure in which an organ is removed from one body and placed in another to swap the damaged or missing organ. The transplant diagnostic test is mainly performed to reduce the risk of organ rejection. Organ transplantation is performed to treat organ failures such as lungs, liver, kidney, and many more. The rising incidence of chronic and infectious diseases, increasing awareness related to transplant diagnostic procedures, and growing number of stem cell, soft-tissue, and solid organ transplantations are projected to drive market growth over the forecast period.

However, strict regulatory bodies and stringent regulatory policies are expected to restrain market growth during the forecast period.

The global transplant diagnostics market has been segmented, by product and service, screening type, organ type, application type, and end user.

Based on product and service, the global transplant diagnostics market has been categorized as instruments, reagents and consumables, and software and services.

On the basis of screening type, the global transplant diagnostics market is further sub-segmented into pre-transplant screening and post-transplant screening.

By organ type, the global transplant diagnostics market is further sub-segmented into kidney, liver, heart, lung, pancreas, and others.

On the basis of application type, the global transplant diagnostics market is further sub-segmented into research application, diagnostics applications, and others.

On the basis of end user, the market has been classified as commercial services providers, hospitals and transplant centers, research laboratories, and academics institutes and others

The global transplant diagnostics market was valued at USD 1,326.4 million in 2017 and is expected to register a CAGR of 7.81% during the forecast period from 2018 to 2023.

Key Players

Some of the key players in the global transplant diagnostics market are Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc, F. Hoffmann-La Roche AG, Qiagen N.V, BioMerieux SA, Illumina, Inc, Becton, Dickinson and Company, Caredx, Inc, Gendx, Zimmer Biomet, Medtronic PLC, DiaSorin S.P.A, Merck KGaA, and Immucor, Inc.

Objectives of the Study

To provide a detailed analysis of the market structure along with a forecast of various segments and sub-segments of the global transplant diagnostics market

To provide insights into factors influencing and affecting market growth

To provide historical and forecast revenue of market segments and sub-segments with respect to countries

To provide strategic profiling of key players in the market and comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market

To provide economic factors that influence the global transplant diagnostics market

To provide a detailed analysis of the value chain and supply chain of the global transplant diagnostics market

Target Audience

Research and Development (R&D) Companies

Academic Institutes and Universities

Pharmaceutical Companies

Raw Material Suppliers

Suppliers and Distributors

Transplant Diagnostics Kits Manufacturers

Government

Potential Investors

Key Findings

The global transplant diagnostics market is expected to reach USD 2,074.7 million by 2023 at a CAGR of 7.81% from 2018 to 2023

Based on products and services, the reagents and consumables segment holds the largest market share and is expected to reach USD 1,027.54 million by 2023 at a CAGR of 8.4% from 2018 to 2023

The market in the Americas is expected to account for the largest share of the global transplant diagnostics market and is projected to reach USD 666.78 million by 2023

The transplant diagnostics market in Asia-Pacific is projected to be the fastest-growing at a CAGR of 8.52% from 2018 to 2023

Regional Analysis

Americas

o North America

? US

? Canada

o Latin America

Europe

o Western Europe

? Germany

? France

? UK

? Italy

? Spain

? Rest of Western Europe

o Eastern Europe

Asia-Pacific

o Japan

o China

o India

o Australia

o South Korea

o Rest of Asia-Pacific

Middle East & Africa

o Middle East

o Africa

READ MORE

Table Of Content

Scope

Table of Contents:

1 Report Prologue

2 Executive Summary

3 Market Introduction

3.1 Scope of Study

3.2 Research Objective

3.3 List of Assumptions

3.4 Market Structure

4 Research Methodology

4.1 Primary Research Methodology

4.2 Data points received from the Specialist Doctors:

4.3 Data points received from the Manufacturer/ Pharmaceutical Companies:

4.4 Data points received from Hospitals, Diagnostic Centers:

4.5 Secondary Research Methodology

4.6 Market Share Analysis

4.7 Trade Analysis

4.8 Market Pricing Approach

4.9 Forecast Model

5 Market Dynamics

5.1 Introduction

5.2 Drivers

5.2.1 Growing number of stem cell, soft-tissue, and solid organ, transplantation procedures

5.2.2 Rising occurrence of chronic and infectious diseases

5.2.3 Increasing Awareness Related to Transplant Diagnostic Procedures

5.3 Restraints

5.3.1 Shortage of donor organ and limited medical reimbursement

5.3.2 High cost of NGS- and PCR-based devices

5.4 Opportunities

5.4.1 High demand for tissue engineering in cosmetic and reconstructive surgery

5.4.2 Growing geriatric population presents a significant growth opportunity

6 Market Factor Analysis

6.1 Porters Five Forces Analysis

6.1.1 Bargaining Power of Suppliers

6.1.2 Bargaining Power of Buyers

6.1.3 Threat of New Entrants

6.1.4 Threat of Substitutes

6.1.5 Intensity of Rivalry

6.2 Supply Chain Analysis

6.2.1 Primary activities

6.2.2 Secondary Activities

7 Immunosuppressant Drug Monitoring (ISD)

7.1 Overview

7.1 Diagnostic Tests for Transplantation

7.1.1 Therapeutic Drug Monitoring During Transplantation

7.2 Americas

7.2.1 North America

7.2.1.1 U.S.

7.2.1.2 Canada

7.2.2 South America

7.3 Europe

7.3.1 Germany

7.3.2 U.K

7.3.3 France

7.3.4 Spain

7.3.5 Italy

7.3.6 Rest of Europe

7.4 Asia Pacific

7.4.1 China

7.4.2 Japan

7.4.3 India

7.4.4 Australia

7.4.5 Rest of Asia Pacific

7.5 Middle East & Africa

7.5.1 Middle East

7.5.2 Africa

8 Global Transplant Diagnostics Market, By Products and Services

8.1 Introduction

8.1.1 Instruments

8.1.2 Reagents & Consumables

8.1.3 Software and Services

9 Global Transplant Diagnostics Market, By Screening Type

9.1 Introduction

9.1.1 Pre-Transplant Screening

9.1.2 Post-Transplant Screening

10 Global Transplant Diagnostics Market, By Organ Type

10.1 Introduction

10.1.1 Kidney

10.1.2 Liver

10.1.3 Heart

10.1.4 Lung

10.1.5 Pancreas

11 Global Transplant Diagnostics Market, By Application Type

11.1 Introduction

11.1.1 Research Applications

11.1.2 Diagnostic Applications

12 Global Transplant Diagnostics Market, By End User

12.1 Introduction

12.1.1 Commercial Service Providers

12.1.2 Hospitals and Transplant Centres

12.1.3 Research Laboratories and Academic Institutes

13 Global Transplant Diagnostics Market, By Region

13.1 Introduction

13.2 Americas

13.2.1 North America

13.2.1.1 U.S.

13.2.1.2 Canada

13.2.2 South America

13.3 Europe

13.3.1 Germany

13.3.2 U.K

13.3.3 France

13.3.4 Spain

13.3.5 Italy

13.3.6 Rest of Europe

13.4 Asia Pacific

13.4.1 China

13.4.2 Japan

13.4.3 India

13.4.4 Australia

13.4.5 Rest of Asia Pacific

13.5 Middle East & Africa

13.5.1 Middle East

13.5.2 Africa

14 Competitive Landscape

14.1 Company Market Share Analysis

14.1.1 Introduction

14.2 Competitive Landscape

14.2.1 Introduction

14.3 Key Developments

15 Company Profiles

15.1 Thermo Fisher Scientific Inc.

15.1.1 Company Overview

15.1.2 Financial Overview

15.1.3 Products Offering

15.1.4 Key Developments

15.1.5 SWOT Analysis

15.1.6 Key Strategy

15.2 Bio-Rad Laboratories, Inc.

15.2.1 Company Overview

15.2.2 Financial Overview

15.2.3 Products Offering

15.2.4 Key Developments

15.2.5 SWOT Analysis

15.2.6 Key Strategy

15.3 F. Hoffmann-La Roche AG

15.3.1 Company Overview

15.3.2 Financial Overview

15.3.3 Products Offering

15.3.4 Key Developments

15.3.5 SWOT Analysis

15.3.6 Key Strategy

15.4 Qiagen N.V.

15.4.1 Company Overview

15.4.2 Financial Overview

15.4.3 Products Offering

15.4.4 Key Developments

15.4.5 SWOT Analysis

15.4.6 Key strategy

15.5 BioMerieux SA

15.5.1 Company Overview

15.5.2 Financial Overview

15.5.3 Products Offering

15.5.4 Key Developments

15.5.5 SWOT Analysis

15.5.6 Key Strategy

15.6 Illumina, Inc.

15.6.1 Company Overview

15.6.2 Financial Overview

15.6.3 Products Offering

15.6.4 Key Developments

15.6.5 SWOT Analysis

15.6.6 Key Strategy

15.7 Becton, Dickinson and Company

15.7.1 Company Overview

15.7.2 Financial Overview

15.7.3 Products Offering

15.7.4 Key Developments

15.7.5 SWOT Analysis

15.7.6 Key Strategy

15.8 Caredx, Inc.

15.8.1 Company Overview

15.8.2 Financial Overview

15.8.3 Products Offering

15.8.4 Key Developments

15.8.5 SWOT Analysis

15.8.6 Key Strategy

15.9 Gendx

15.9.1 Company Overview

15.9.2 Financial Overview

15.9.3 Products Offering

15.9.4 Key Developments

15.9.5 SWOT Analysis

15.9.6 Key Strategy

15.1 Zimmer Biomet

15.10.1 Company Overview

15.10.2 Financial Overview

15.10.3 Products Offering

15.10.4 Key Developments

15.10.5 SWOT Analysis

15.10.6 Key Strategy

15.11 Medtronic PLC

15.11.1 Company Overview

15.11.2 Financial Overview

15.11.3 Products Offering

15.11.4 Key Developments

15.11.5 SWOT Analysis

15.11.6 Key Strategy

15.12 DiaSorin S.P.A

15.12.1 Company Overview

15.12.2 Financial Overview

15.12.3 Products Offering

15.12.4 Key Developments

15.12.5 SWOT Analysis

15.12.6 Key Strategy

15.13 Merck KGaA

15.13.1 Company Overview

15.13.2 Financial Overview

15.13.3 Products Offering

15.13.4 Key Developments

15.13.5 SWOT Analysis

15.13.6 Key Strategy

15.14 Immucor, Inc.

15.14.1 Company Overview

15.14.2 Financial Overview:

15.14.3 Products Offering

15.14.4 Key Developments

15.14.5 SWOT Analysis

15.14.6 Key strategy

16 Appendix

16.1 Discussion Blue Print

16.2 Reference


List Of Figure

List of Figures:

FIGURE 1 GLOBAL TRANSPLANT DIAGNOSTICS MARKET: MARKET STRUCTURE

FIGURE 2 RESEARCH METHODOLOGY

FIGURE 3 DATA TRIANGULATION METHOD

FIGURE 4 TOP DOWN & BOTTOM UP APPROACH

FIGURE 5 GLOBAL TRANSPLANT DIAGNOSTICS MARKET: MICHAEL PORTER'S FIVE FORCES MODEL

FIGURE 6 GLOBAL TRANSPLANT DIAGNOSTICS MARKET: SUPPLY CHAIN ANALYSIS

FIGURE 7 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2017 & 2023 (USD MILLION)

FIGURE 8 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY SCREENING TYPE 2017 & 2023 (USD MILLION)

FIGURE 9 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY ORGAN TYPE 2017 & 2023 (USD MILLION)

FIGURE 10 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 2017 & 2023 (USD MILLION)

FIGURE 11 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2017 & 2023 (USD MILLION)

FIGURE 12 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY REGION 2017 & 2023 (USD MILLION)

FIGURE 13 AMERICAS TRANSPLANT DIAGNOSTICS MARKET, BY REGION 2017 & 2023 (USD MILLION)

FIGURE 14 NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY 2017 (%)

FIGURE 15 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY 2017 (%)

FIGURE 16 ASIA PACFIC TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY 2017 & 2023 (USD MILLION)

FIGURE 17 MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY 2017 & 2023 (USD MILLION)

FIGURE 18 GLOBAL TRANSPLANT DIAGNOSTIC MARKET, MARKET SHARE ANALYSIS 2017 (%)

FIGURE 19 GLOBAL TRANSPLANT DIAGNOSTIC MARKET COMPETITIVE LANDSCAPE (%)


List Of Table

List of Tables:

TABLE 1 MARKET SYNOPSIS

TABLE 2 LIST OF ASSUMPTIONS

TABLE 3 PRIMARY INTERVIEWS

TABLE 4 GLOBAL IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY REGION 2015-2023 (USD MILLION)

TABLE 5 AMERICAS TRANSPLANT DIAGNOSTICS MARKET, BY REGION 2015-2023 (USD MILLION)

TABLE 6 NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY 2015-2023 (USD MILLION)

TABLE 7 NORTH AMERICA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING

2015-2023 (USD MILLION)

TABLE 8 NORTH AMERICA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG

2015-2023 (USD MILLION)

TABLE 9 NORTH AMERICA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2015-2023 (USD MILLION)

TABLE 10 US IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2015-2023 (USD MILLION)

TABLE 11 US IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG 2015-2023 (USD MILLION)

TABLE 12 US IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2015-2023 (USD MILLION)

TABLE 13 CANADA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2015-2023 (USD MILLION)

TABLE 14 CANADA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG 2015-2023 (USD MILLION)

TABLE 15 CANADA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2015-2023 (USD MILLION)

TABLE 16 SOUTH AMERICA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING

2015-2023 (USD MILLION)

TABLE 17 SOUTH AMERICA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG

2015-2023 (USD MILLION)

TABLE 18 SOUTH AMERICA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2015-2023 (USD MILLION)

TABLE 19 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY 2015-2023 (USD MILLION)

TABLE 20 EUROPE IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2015-2023 (USD MILLION)

TABLE 21 EUROPE IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG 2015-2023 (USD MILLION)

TABLE 22 EUROPE IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2015-2023 (USD MILLION)

TABLE 23 GERMANY IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2015-2023 (USD MILLION)

TABLE 24 GERMANY IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG 2015-2023 (USD MILLION)

TABLE 25 GERMANY IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2015-2023 (USD MILLION)

TABLE 26 U.K TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2015-2023 (USD MILLION)

TABLE 27 U.K TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2015-2023 (USD MILLION)

TABLE 28 U.K TRANSPLANT DIAGNOSTICS MARKET, BY ASSAY & KITS 2015-2023 (USD MILLION)

TABLE 29 FRANCE IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2015-2023 (USD MILLION)

TABLE 30 FRANCE IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG 2015-2023 (USD MILLION)

TABLE 31 FRANCE IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2015-2023 (USD MILLION)

TABLE 32 SPAIN IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2015-2023 (USD MILLION)

TABLE 33 SPAIN IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG 2015-2023 (USD MILLION)

TABLE 34 SPAIN IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2015-2023 (USD MILLION)

TABLE 35 ITALY IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2015-2023 (USD MILLION)

TABLE 36 ITALY IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG 2015-2023

(USD MILLION)

TABLE 37 ITALY IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2015-2023 (USD MILLION)

TABLE 38 REST OF EUROPE IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING

2015-2023 (USD MILLION)

TABLE 39 REST OF EUROPE IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG

2015-2023 (USD MILLION)

TABLE 40 REST OF EUROPE IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2015-2023 (USD MILLION)

TABLE 41 ASIA PACFIC TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY 2015-2023 (USD MILLION)

TABLE 42 ASIA PACIFIC IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2015-2023 (USD MILLION)

TABLE 43 ASIA PACIFIC IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG

2015-2023 (USD MILLION)

TABLE 44 ASIA PACIFIC IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2015-2023 (USD MILLION)

TABLE 45 CHINA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2015-2023 (USD MILLION)

TABLE 46 CHINA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG 2015-2023 (USD MILLION)

TABLE 47 CHINA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2015-2023 (USD MILLION)

TABLE 48 JAPAN IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2015-2023 (USD MILLION)

TABLE 49 JAPAN IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG 2015-2023 (USD MILLION)

TABLE 50 JAPAN IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2015-2023 (USD MILLION)

TABLE 51 INDIA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2015-2023 (USD MILLION)

TABLE 52 INDIA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG 2015-2023 (USD MILLION)

TABLE 53 INDIA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2015-2023 (USD MILLION)

TABLE 54 AUSTRALIA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2015-2023 (USD MILLION)

TABLE 55 AUSTRALIA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG

2015-2023 (USD MILLION)

TABLE 56 AUSTRALIA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2015-2023 (USD MILLION)

TABLE 57 REST OF APAC IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2015-2023 (USD MILLION)

TABLE 58 REST OF APAC IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG

2015-2023 (USD MILLION)

TABLE 59 REST OF APAC IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2015-2023 (USD MILLION)

TABLE 60 MIDDLE EAST & AFRICA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY REGION 2015-2023 (USD MILLION)

TABLE 61 MIDDLE EAST & AFRICA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING

2015-2023 (USD MILLION)

TABLE 62 MIDDLE EAST & AFRICA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG

2015-2023 (USD MILLION)

TABLE 63 MIDDLE EAST & AFRICA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2015-2023 (USD MILLION)

TABLE 64 MIDDLE EAST IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2015-2023 (USD MILLION)

TABLE 65 MIDDLE EAST IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG

2015-2023 (USD MILLION)

TABLE 66 MIDDLE EAST IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2015-2023 (USD MILLION)

TABLE 67 AFRICA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2015-2023 (USD MILLION)

TABLE 68 AFRICA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG 2015-2023 (USD MILLION)

TABLE 69 AFRICA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2015-2023 (USD MILLION)

TABLE 70 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2015-2023 (USD MILLION)

TABLE 71 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2015-2023 (USD MILLION)

TABLE 72 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY ASSAY & KITS 2015-2023 (USD MILLION)

TABLE 73 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2015-2023 (USD MILLION)

TABLE 74 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2015-2023 (USD MILLION)

TABLE 75 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY SEQUENCING-BASED ASSAY 2015-2023 (USD MILLION)

TABLE 76 GLOBAL TRANSPLANT DIAGNOSTICS MARKET FOR INSTRUMENTS, BY REGION 2015-2023 (USD MILLION)

TABLE 77 GLOBAL TRANSPLANT DIAGNOSTICS MARKET FOR REAGENTS & CONSUMABLES, BY REGION 2015-2023 (USD MILLION)

TABLE 78 GLOBAL TRANSPLANT DIAGNOSTICS MARKET FOR SOFTWARE AND SERVICES, BY REGION 2015-2023 (USD MILLION)

TABLE 79 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY SCREENING TYPE 2015-2023 (USD MILLION)

TABLE 80 GLOBAL TRANSPLANT DIAGNOSTICS MARKET FOR PRE-TRANSPLANT SCREENING, BY REGION 2015-2023 (USD MILLION)

TABLE 81 GLOBAL TRANSPLANT DIAGNOSTICS MARKET FOR POST-TRANSPLANT SCREENING, BY REGION 2015-2023 (USD MILLION)

TABLE 82 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY ORGAN TYPE 2015-2023 (USD MILLION)

TABLE 83 GLOBAL TRANSPLANT DIAGNOSTICS MARKET FOR KIDNEY, BY REGION 2015-2023 (USD MILLION)

TABLE 84 GLOBAL TRANSPLANT DIAGNOSTICS MARKET FOR LIVER, BY REGION 2015-2023 (USD MILLION)

TABLE 85 GLOBAL TRANSPLANT DIAGNOSTICS MARKET FOR HEART, BY REGION 2015-2023 (USD MILLION)

TABLE 86 GLOBAL TRANSPLANT DIAGNOSTICS MARKET FOR LUNG, BY REGION 2015-2023 (USD MILLION)

TABLE 87 GLOBAL TRANSPLANT DIAGNOSTICS MARKET FOR PANCREAS, BY REGION 2015-2023 (USD MILLION)

TABLE 88 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 89 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY DIAGNOSTIC APPLICATIONS 2015-2023 (USD MILLION)

TABLE 90 GLOBAL TRANSPLANT DIAGNOSTICS MARKET FOR RESEARCH APPLICATIONS, BY REGION 2015-2023 (USD MILLION)

TABLE 91 GLOBAL TRANSPLANT DIAGNOSTICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION 2015-2023 (USD MILLION)

TABLE 92 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 93 GLOBAL TRANSPLANT DIAGNOSTICS MARKET FOR COMMERCIAL SERVICE PROVIDERS, BY REGION 2015-2023 (USD MILLION)

TABLE 94 GLOBAL TRANSPLANT DIAGNOSTICS MARKET FOR HOSPITALS AND TRANSPLANT CENTERS, BY REGION

2015-2023 (USD MILLION)

TABLE 95 GLOBAL TRANSPLANT DIAGNOSTICS MARKET FOR RESEARCH LABORATORIES AND ACADEMIC INSTITUTES, BY REGION

2015-2023 (USD MILLION)

TABLE 96 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY REGION 2015-2023 (USD MILLION)

TABLE 97 AMERICAS TRANSPLANT DIAGNOSTICS MARKET, BY REGION 2015-2023 (USD MILLION)

TABLE 98 NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY 2015-2023 (USD MILLION)

TABLE 99 NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2015-2023 (USD MILLION)

TABLE 100 NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2015-2023 (USD MILLION)

TABLE 101 NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY ASSAY & KITS 2015-2023 (USD MILLION)

TABLE 102 NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2015-2023 (USD MILLION)

TABLE 103 NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2015-2023 (USD MILLION)

TABLE 104 NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY SEQUENCING-BASED ASSAY 2015-2023 (USD MILLION)

TABLE 105 NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY SCREENING TYPE 2015-2023 (USD MILLION)

TABLE 106 NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY ORGAN TYPE 2015-2023 (USD MILLION)

TABLE 107 NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 108 NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY DIAGNOSTIC APPLICATIONS 2015-2023 (USD MILLION)

TABLE 109 NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 110 U.S. TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2015-2023 (USD MILLION)

TABLE 111 U.S. TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2015-2023 (USD MILLION)

TABLE 112 U.S. TRANSPLANT DIAGNOSTICS MARKET, BY ASSAY & KITS 2015-2023 (USD MILLION)

TABLE 113 U.S. TRANSPLANT DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2015-2023 (USD MILLION)

TABLE 114 U.S. TRANSPLANT DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2015-2023 (USD MILLION)

TABLE 115 U.S. TRANSPLANT DIAGNOSTICS MARKET, BY SEQUENCING-BASED ASSAY 2015-2023 (USD MILLION)

TABLE 116 U.S. TRANSPLANT DIAGNOSTICS MARKET, BY SCREENING TYPE 2015-2023 (USD MILLION)

TABLE 117 U.S. TRANSPLANT DIAGNOSTICS MARKET, BY ORGAN TYPE 2015-2023 (USD MILLION)

TABLE 118 U.S. TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 119 U.S. TRANSPLANT DIAGNOSTICS MARKET, BY DIAGNOSTIC APPLICATIONS 2015-2023 (USD MILLION)

TABLE 120 U.S. TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 121 CANADA TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2015-2023 (USD MILLION)

TABLE 122 CANADA TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2015-2023 (USD MILLION)

TABLE 123 CANADA TRANSPLANT DIAGNOSTICS MARKET, BY ASSAY & KITS 2015-2023 (USD MILLION)

TABLE 124 CANADA TRANSPLANT DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2015-2023 (USD MILLION)

TABLE 125 CANADA TRANSPLANT DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2015-2023 (USD MILLION)

TABLE 126 CANADA TRANSPLANT DIAGNOSTICS MARKET, BY SEQUENCING-BASED ASSAY 2015-2023 (USD MILLION)

TABLE 127 CANADA TRANSPLANT DIAGNOSTICS MARKET, BY SCREENING TYPE 2015-2023 (USD MILLION)

TABLE 128 CANADA TRANSPLANT DIAGNOSTICS MARKET, BY ORGAN TYPE 2015-2023 (USD MILLION)

TABLE 129 CANADA TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 130 CANADA TRANSPLANT DIAGNOSTICS MARKET, BY DIAGNOSTIC APPLICATIONS 2015-2023 (USD MILLION)

TABLE 131 CANADA TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 132 SOUTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2015-2023 (USD MILLION)

TABLE 133 SOUTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2015-2023 (USD MILLION)

TABLE 134 SOUTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY ASSAY & KITS 2015-2023 (USD MILLION)

TABLE 135 SOUTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2015-2023 (USD MILLION)

TABLE 136 SOUTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2015-2023 (USD MILLION)

TABLE 137 SOUTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY SEQUENCING-BASED ASSAY 2015-2023 (USD MILLION)

TABLE 138 SOUTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY SCREENING TYPE 2015-2023 (USD MILLION)

TABLE 139 SOUTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY ORGAN TYPE 2015-2023 (USD MILLION)

TABLE 140 SOUTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 141 SOUTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY DIAGNOSTIC APPLICATIONS 2015-2023 (USD MILLION)

TABLE 142 SOUTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 143 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY 2015-2023 (USD MILLION)

TABLE 144 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2015-2023 (USD MILLION)

TABLE 145 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2015-2023 (USD MILLION)

TABLE 146 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY ASSAY & KITS 2015-2023 (USD MILLION)

TABLE 147 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2015-2023 (USD MILLION)

TABLE 148 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2015-2023 (USD MILLION)

TABLE 149 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY SEQUENCING-BASED ASSAY 2015-2023 (USD MILLION)

TABLE 150 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY SCREENING TYPE 2015-2023 (USD MILLION)

TABLE 151 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY ORGAN TYPE 2015-2023 (USD MILLION)

TABLE 152 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 153 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY DIAGNOSTIC APPLICATIONS 2015-2023 (USD MILLION)

TABLE 154 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 155 GERMANY TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2015-2023 (USD MILLION)

TABLE 156 GERMANY TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2015-2023 (USD MILLION)

TABLE 157 GERMANY TRANSPLANT DIAGNOSTICS MARKET, BY ASSAY & KITS 2015-2023 (USD MILLION)

TABLE 158 GERMANY TRANSPLANT DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2015-2023 (USD MILLION)

TABLE 159 GERMANY TRANSPLANT DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2015-2023 (USD MILLION)

TABLE 160 GERMANY TRANSPLANT DIAGNOSTICS MARKET, BY SEQUENCING-BASED ASSAY 2015-2023 (USD MILLION)

TABLE 161 GERMANY TRANSPLANT DIAGNOSTICS MARKET, BY SCREENING TYPE 2015-2023 (USD MILLION)

TABLE 162 GERMANY TRANSPLANT DIAGNOSTICS MARKET, BY ORGAN TYPE 2015-2023 (USD MILLION)

TABLE 163 GERMANY TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 164 GERMANY TRANSPLANT DIAGNOSTICS MARKET, BY DIAGNOSTIC APPLICATIONS 2015-2023 (USD MILLION)

TABLE 165 GERMANY TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 166 U.K TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2015-2023 (USD MILLION)

TABLE 167 U.K TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2015-2023 (USD MILLION)

TABLE 168 U.K TRANSPLANT DIAGNOSTICS MARKET, BY ASSAY & KITS 2015-2023 (USD MILLION)

TABLE 169 U.K TRANSPLANT DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2015-2023 (USD MILLION)

TABLE 170 U.K TRANSPLANT DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2015-2023 (USD MILLION)

TABLE 171 U.K TRANSPLANT DIAGNOSTICS MARKET, BY SEQUENCING-BASED ASSAY 2015-2023 (USD MILLION)

TABLE 172 U.K TRANSPLANT DIAGNOSTICS MARKET, BY SCREENING TYPE 2015-2023 (USD MILLION)

TABLE 173 U.K TRANSPLANT DIAGNOSTICS MARKET, BY ORGAN TYPE 2015-2023 (USD MILLION)

TABLE 174 U.K TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 175 U.K TRANSPLANT DIAGNOSTICS MARKET, BY DIAGNOSTIC APPLICATIONS 2015-2023 (USD MILLION)

TABLE 176 U.K TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 177 FRANCE TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2015-2023 (USD MILLION)

TABLE 178 FRANCE TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2015-2023 (USD MILLION)

TABLE 179 FRANCE TRANSPLANT DIAGNOSTICS MARKET, BY ASSAY & KITS 2015-2023 (USD MILLION)

TABLE 180 FRANCE TRANSPLANT DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2015-2023 (USD MILLION)

TABLE 181 FRANCE TRANSPLANT DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2015-2023 (USD MILLION)

TABLE 182 FRANCE TRANSPLANT DIAGNOSTICS MARKET, BY SEQUENCING-BASED ASSAY 2015-2023 (USD MILLION)

TABLE 183 FRANCE TRANSPLANT DIAGNOSTICS MARKET, BY SCREENING TYPE 2015-2023 (USD MILLION)

TABLE 184 FRANCE TRANSPLANT DIAGNOSTICS MARKET, BY ORGAN TYPE 2015-2023 (USD MILLION)

TABLE 185 FRANCE TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 186 FRANCE TRANSPLANT DIAGNOSTICS MARKET, BY DIAGNOSTIC APPLICATIONS 2015-2023 (USD MILLION)

TABLE 187 FRANCE TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 188 SPAIN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2015-2023 (USD MILLION)

TABLE 189 SPAIN TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2015-2023 (USD MILLION)

TABLE 190 SPAIN TRANSPLANT DIAGNOSTICS MARKET, BY ASSAY & KITS 2015-2023 (USD MILLION)

TABLE 191 SPAIN TRANSPLANT DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2015-2023 (USD MILLION)

TABLE 192 SPAIN TRANSPLANT DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2015-2023 (USD MILLION)

TABLE 193 SPAIN TRANSPLANT DIAGNOSTICS MARKET, BY SEQUENCING-BASED ASSAY 2015-2023 (USD MILLION)

TABLE 194 SPAIN TRANSPLANT DIAGNOSTICS MARKET, BY SCREENING TYPE 2015-2023 (USD MILLION)

TABLE 195 SPAIN TRANSPLANT DIAGNOSTICS MARKET, BY ORGAN TYPE 2015-2023 (USD MILLION)

TABLE 196 SPAIN TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 197 SPAIN TRANSPLANT DIAGNOSTICS MARKET, BY DIAGNOSTIC APPLICATIONS 2015-2023 (USD MILLION)

TABLE 198 SPAIN TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 199 ITALY TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2015-2023 (USD MILLION)

TABLE 200 ITALY TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2015-2023 (USD MILLION)

TABLE 201 ITALY TRANSPLANT DIAGNOSTICS MARKET, BY ASSAY & KITS 2015-2023 (USD MILLION)

TABLE 202 ITALY TRANSPLANT DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2015-2023 (USD MILLION)

TABLE 203 ITALY TRANSPLANT DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2015-2023 (USD MILLION)

TABLE 204 ITALY TRANSPLANT DIAGNOSTICS MARKET, BY SEQUENCING-BASED ASSAY 2015-2023 (USD MILLION)

TABLE 205 ITALY TRANSPLANT DIAGNOSTICS MARKET, BY SCREENING TYPE 2015-2023 (USD MILLION)

TABLE 206 ITALY TRANSPLANT DIAGNOSTICS MARKET, BY ORGAN TYPE 2015-2023 (USD MILLION)

TABLE 207 ITALY TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 208 ITALY TRANSPLANT DIAGNOSTICS MARKET, BY DIAGNOSTIC APPLICATIONS 2015-2023 (USD MILLION)

TABLE 209 ITALY TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 210 REST OF EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2015-2023 (USD MILLION)

TABLE 211 REST OF EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2015-2023 (USD MILLION)

TABLE 212 REST OF EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY ASSAY & KITS 2015-2023 (USD MILLION)

TABLE 213 REST OF EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2015-2023 (USD MILLION)

TABLE 214 REST OF EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2015-2023 (USD MILLION)

TABLE 215 REST OF EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY SEQUENCING-BASED ASSAY 2015-2023 (USD MILLION)

TABLE 216 REST OF EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY SCREENING TYPE 2015-2023 (USD MILLION)

TABLE 217 REST OF EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY ORGAN TYPE 2015-2023 (USD MILLION)

TABLE 218 REST OF EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 219 REST OF EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY DIAGNOSTIC APPLICATIONS 2015-2023 (USD MILLION)

TABLE 220 REST OF EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 221 ASIA PACFIC TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY 2015-2023 (USD MILLION)

TABLE 222 ASIA PACIFIC TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2015-2023 (USD MILLION)

TABLE 223 ASIA PACIFIC TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2015-2023 (USD MILLION)

TABLE 224 ASIA PACIFIC TRANSPLANT DIAGNOSTICS MARKET, BY ASSAY & KITS 2015-2023 (USD MILLION)

TABLE 225 ASIA PACIFIC TRANSPLANT DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2015-2023 (USD MILLION)

TABLE 226 ASIA PACIFIC TRANSPLANT DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2015-2023 (USD MILLION)

TABLE 227 ASIA PACIFIC TRANSPLANT DIAGNOSTICS MARKET, BY SEQUENCING-BASED ASSAY 2015-2023 (USD MILLION)

TABLE 228 ASIA PACIFIC TRANSPLANT DIAGNOSTICS MARKET, BY SCREENING TYPE 2015-2023 (USD MILLION)

TABLE 229 ASIA PACIFIC TRANSPLANT DIAGNOSTICS MARKET, BY ORGAN TYPE 2015-2023 (USD MILLION)

TABLE 230 ASIA PACIFIC TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 231 ASIA PACIFIC TRANSPLANT DIAGNOSTICS MARKET, BY DIAGNOSTIC APPLICATIONS 2015-2023 (USD MILLION)

TABLE 232 ASIA PACIFIC TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 233 CHINA TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2015-2023 (USD MILLION)

TABLE 234 CHINA TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2015-2023 (USD MILLION)

TABLE 235 CHINA TRANSPLANT DIAGNOSTICS MARKET, BY ASSAY & KITS 2015-2023 (USD MILLION)

TABLE 236 CHINA TRANSPLANT DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2015-2023 (USD MILLION)

TABLE 237 CHINA TRANSPLANT DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2015-2023 (USD MILLION)

Licence Rights

"Single User License: OnIine PDF View Only
Enterprise-user License : Print & download option is available."

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies


Companies

Thermo Fisher Scientific Inc.

Bio-Rad Laboratories, Inc.

F. Hoffmann-La Roche AG

Qiagen N.V.

BioMerieux SA

Illumina, Inc.

Becton, Dickinson and Company

Caredx, Inc.

Gendx

Zimmer Biomet

Medtronic PLC

DiaSorin S.P.A

Merck KGaA

Immucor, Inc.

Company Profile

Company Profile Title

Introduction

Transplant diagnostic is a test which is performed during organ transplantation to identify the compatibility of the organ. It is a medical procedure in which an organ is removed from one body and placed in another to swap the damaged or missing organ. The transplant diagnostic test is mainly performed to reduce the risk of organ rejection. Organ transplantation is performed to treat organ failures such as lungs, liver, kidney, and many more. The rising incidence of chronic and infectious diseases, increasing awareness related to transplant diagnostic procedures, and growing number of stem cell, soft-tissue, and solid organ transplantations are projected to drive market growth over the forecast period.

However, strict regulatory bodies and stringent regulatory policies are expected to restrain market growth during the forecast period.

The global transplant diagnostics market has been segmented, by product and service, screening type, organ type, application type, and end user.

Based on product and service, the global transplant diagnostics market has been categorized as instruments, reagents and consumables, and software and services.

On the basis of screening type, the global transplant diagnostics market is further sub-segmented into pre-transplant screening and post-transplant screening.

By organ type, the global transplant diagnostics market is further sub-segmented into kidney, liver, heart, lung, pancreas, and others.

On the basis of application type, the global transplant diagnostics market is further sub-segmented into research application, diagnostics applications, and others.

On the basis of end user, the market has been classified as commercial services providers, hospitals and transplant centers, research laboratories, and academics institutes and others

The global transplant diagnostics market was valued at USD 1,326.4 million in 2017 and is expected to register a CAGR of 7.81% during the forecast period from 2018 to 2023.

Key Players

Some of the key players in the global transplant diagnostics market are Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc, F. Hoffmann-La Roche AG, Qiagen N.V, BioMerieux SA, Illumina, Inc, Becton, Dickinson and Company, Caredx, Inc, Gendx, Zimmer Biomet, Medtronic PLC, DiaSorin S.P.A, Merck KGaA, and Immucor, Inc.

Objectives of the Study

To provide a detailed analysis of the market structure along with a forecast of various segments and sub-segments of the global transplant diagnostics market

To provide insights into factors influencing and affecting market growth

To provide historical and forecast revenue of market segments and sub-segments with respect to countries

To provide strategic profiling of key players in the market and comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market

To provide economic factors that influence the global transplant diagnostics market

To provide a detailed analysis of the value chain and supply chain of the global transplant diagnostics market

Target Audience

Research and Development (R&D) Companies

Academic Institutes and Universities

Pharmaceutical Companies

Raw Material Suppliers

Suppliers and Distributors

Transplant Diagnostics Kits Manufacturers

Government

Potential Investors

Key Findings

The global transplant diagnostics market is expected to reach USD 2,074.7 million by 2023 at a CAGR of 7.81% from 2018 to 2023

Based on products and services, the reagents and consumables segment holds the largest market share and is expected to reach USD 1,027.54 million by 2023 at a CAGR of 8.4% from 2018 to 2023

The market in the Americas is expected to account for the largest share of the global transplant diagnostics market and is projected to reach USD 666.78 million by 2023

The transplant diagnostics market in Asia-Pacific is projected to be the fastest-growing at a CAGR of 8.52% from 2018 to 2023

Regional Analysis

Americas

o North America

? US

? Canada

o Latin America

Europe

o Western Europe

? Germany

? France

? UK

? Italy

? Spain

? Rest of Western Europe

o Eastern Europe

Asia-Pacific

o Japan

o China

o India

o Australia

o South Korea

o Rest of Asia-Pacific

Middle East & Africa

o Middle East

o Africa

READ MORE

Scope

Table of Contents:

1 Report Prologue

2 Executive Summary

3 Market Introduction

3.1 Scope of Study

3.2 Research Objective

3.3 List of Assumptions

3.4 Market Structure

4 Research Methodology

4.1 Primary Research Methodology

4.2 Data points received from the Specialist Doctors:

4.3 Data points received from the Manufacturer/ Pharmaceutical Companies:

4.4 Data points received from Hospitals, Diagnostic Centers:

4.5 Secondary Research Methodology

4.6 Market Share Analysis

4.7 Trade Analysis

4.8 Market Pricing Approach

4.9 Forecast Model

5 Market Dynamics

5.1 Introduction

5.2 Drivers

5.2.1 Growing number of stem cell, soft-tissue, and solid organ, transplantation procedures

5.2.2 Rising occurrence of chronic and infectious diseases

5.2.3 Increasing Awareness Related to Transplant Diagnostic Procedures

5.3 Restraints

5.3.1 Shortage of donor organ and limited medical reimbursement

5.3.2 High cost of NGS- and PCR-based devices

5.4 Opportunities

5.4.1 High demand for tissue engineering in cosmetic and reconstructive surgery

5.4.2 Growing geriatric population presents a significant growth opportunity

6 Market Factor Analysis

6.1 Porters Five Forces Analysis

6.1.1 Bargaining Power of Suppliers

6.1.2 Bargaining Power of Buyers

6.1.3 Threat of New Entrants

6.1.4 Threat of Substitutes

6.1.5 Intensity of Rivalry

6.2 Supply Chain Analysis

6.2.1 Primary activities

6.2.2 Secondary Activities

7 Immunosuppressant Drug Monitoring (ISD)

7.1 Overview

7.1 Diagnostic Tests for Transplantation

7.1.1 Therapeutic Drug Monitoring During Transplantation

7.2 Americas

7.2.1 North America

7.2.1.1 U.S.

7.2.1.2 Canada

7.2.2 South America

7.3 Europe

7.3.1 Germany

7.3.2 U.K

7.3.3 France

7.3.4 Spain

7.3.5 Italy

7.3.6 Rest of Europe

7.4 Asia Pacific

7.4.1 China

7.4.2 Japan

7.4.3 India

7.4.4 Australia

7.4.5 Rest of Asia Pacific

7.5 Middle East & Africa

7.5.1 Middle East

7.5.2 Africa

8 Global Transplant Diagnostics Market, By Products and Services

8.1 Introduction

8.1.1 Instruments

8.1.2 Reagents & Consumables

8.1.3 Software and Services

9 Global Transplant Diagnostics Market, By Screening Type

9.1 Introduction

9.1.1 Pre-Transplant Screening

9.1.2 Post-Transplant Screening

10 Global Transplant Diagnostics Market, By Organ Type

10.1 Introduction

10.1.1 Kidney

10.1.2 Liver

10.1.3 Heart

10.1.4 Lung

10.1.5 Pancreas

11 Global Transplant Diagnostics Market, By Application Type

11.1 Introduction

11.1.1 Research Applications

11.1.2 Diagnostic Applications

12 Global Transplant Diagnostics Market, By End User

12.1 Introduction

12.1.1 Commercial Service Providers

12.1.2 Hospitals and Transplant Centres

12.1.3 Research Laboratories and Academic Institutes

13 Global Transplant Diagnostics Market, By Region

13.1 Introduction

13.2 Americas

13.2.1 North America

13.2.1.1 U.S.

13.2.1.2 Canada

13.2.2 South America

13.3 Europe

13.3.1 Germany

13.3.2 U.K

13.3.3 France

13.3.4 Spain

13.3.5 Italy

13.3.6 Rest of Europe

13.4 Asia Pacific

13.4.1 China

13.4.2 Japan

13.4.3 India

13.4.4 Australia

13.4.5 Rest of Asia Pacific

13.5 Middle East & Africa

13.5.1 Middle East

13.5.2 Africa

14 Competitive Landscape

14.1 Company Market Share Analysis

14.1.1 Introduction

14.2 Competitive Landscape

14.2.1 Introduction

14.3 Key Developments

15 Company Profiles

15.1 Thermo Fisher Scientific Inc.

15.1.1 Company Overview

15.1.2 Financial Overview

15.1.3 Products Offering

15.1.4 Key Developments

15.1.5 SWOT Analysis

15.1.6 Key Strategy

15.2 Bio-Rad Laboratories, Inc.

15.2.1 Company Overview

15.2.2 Financial Overview

15.2.3 Products Offering

15.2.4 Key Developments

15.2.5 SWOT Analysis

15.2.6 Key Strategy

15.3 F. Hoffmann-La Roche AG

15.3.1 Company Overview

15.3.2 Financial Overview

15.3.3 Products Offering

15.3.4 Key Developments

15.3.5 SWOT Analysis

15.3.6 Key Strategy

15.4 Qiagen N.V.

15.4.1 Company Overview

15.4.2 Financial Overview

15.4.3 Products Offering

15.4.4 Key Developments

15.4.5 SWOT Analysis

15.4.6 Key strategy

15.5 BioMerieux SA

15.5.1 Company Overview

15.5.2 Financial Overview

15.5.3 Products Offering

15.5.4 Key Developments

15.5.5 SWOT Analysis

15.5.6 Key Strategy

15.6 Illumina, Inc.

15.6.1 Company Overview

15.6.2 Financial Overview

15.6.3 Products Offering

15.6.4 Key Developments

15.6.5 SWOT Analysis

15.6.6 Key Strategy

15.7 Becton, Dickinson and Company

15.7.1 Company Overview

15.7.2 Financial Overview

15.7.3 Products Offering

15.7.4 Key Developments

15.7.5 SWOT Analysis

15.7.6 Key Strategy

15.8 Caredx, Inc.

15.8.1 Company Overview

15.8.2 Financial Overview

15.8.3 Products Offering

15.8.4 Key Developments

15.8.5 SWOT Analysis

15.8.6 Key Strategy

15.9 Gendx

15.9.1 Company Overview

15.9.2 Financial Overview

15.9.3 Products Offering

15.9.4 Key Developments

15.9.5 SWOT Analysis

15.9.6 Key Strategy

15.1 Zimmer Biomet

15.10.1 Company Overview

15.10.2 Financial Overview

15.10.3 Products Offering

15.10.4 Key Developments

15.10.5 SWOT Analysis

15.10.6 Key Strategy

15.11 Medtronic PLC

15.11.1 Company Overview

15.11.2 Financial Overview

15.11.3 Products Offering

15.11.4 Key Developments

15.11.5 SWOT Analysis

15.11.6 Key Strategy

15.12 DiaSorin S.P.A

15.12.1 Company Overview

15.12.2 Financial Overview

15.12.3 Products Offering

15.12.4 Key Developments

15.12.5 SWOT Analysis

15.12.6 Key Strategy

15.13 Merck KGaA

15.13.1 Company Overview

15.13.2 Financial Overview

15.13.3 Products Offering

15.13.4 Key Developments

15.13.5 SWOT Analysis

15.13.6 Key Strategy

15.14 Immucor, Inc.

15.14.1 Company Overview

15.14.2 Financial Overview:

15.14.3 Products Offering

15.14.4 Key Developments

15.14.5 SWOT Analysis

15.14.6 Key strategy

16 Appendix

16.1 Discussion Blue Print

16.2 Reference


List Of Figure

List of Figures:

FIGURE 1 GLOBAL TRANSPLANT DIAGNOSTICS MARKET: MARKET STRUCTURE

FIGURE 2 RESEARCH METHODOLOGY

FIGURE 3 DATA TRIANGULATION METHOD

FIGURE 4 TOP DOWN & BOTTOM UP APPROACH

FIGURE 5 GLOBAL TRANSPLANT DIAGNOSTICS MARKET: MICHAEL PORTER'S FIVE FORCES MODEL

FIGURE 6 GLOBAL TRANSPLANT DIAGNOSTICS MARKET: SUPPLY CHAIN ANALYSIS

FIGURE 7 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2017 & 2023 (USD MILLION)

FIGURE 8 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY SCREENING TYPE 2017 & 2023 (USD MILLION)

FIGURE 9 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY ORGAN TYPE 2017 & 2023 (USD MILLION)

FIGURE 10 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 2017 & 2023 (USD MILLION)

FIGURE 11 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2017 & 2023 (USD MILLION)

FIGURE 12 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY REGION 2017 & 2023 (USD MILLION)

FIGURE 13 AMERICAS TRANSPLANT DIAGNOSTICS MARKET, BY REGION 2017 & 2023 (USD MILLION)

FIGURE 14 NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY 2017 (%)

FIGURE 15 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY 2017 (%)

FIGURE 16 ASIA PACFIC TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY 2017 & 2023 (USD MILLION)

FIGURE 17 MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY 2017 & 2023 (USD MILLION)

FIGURE 18 GLOBAL TRANSPLANT DIAGNOSTIC MARKET, MARKET SHARE ANALYSIS 2017 (%)

FIGURE 19 GLOBAL TRANSPLANT DIAGNOSTIC MARKET COMPETITIVE LANDSCAPE (%)


List Of Table

List of Tables:

TABLE 1 MARKET SYNOPSIS

TABLE 2 LIST OF ASSUMPTIONS

TABLE 3 PRIMARY INTERVIEWS

TABLE 4 GLOBAL IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY REGION 2015-2023 (USD MILLION)

TABLE 5 AMERICAS TRANSPLANT DIAGNOSTICS MARKET, BY REGION 2015-2023 (USD MILLION)

TABLE 6 NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY 2015-2023 (USD MILLION)

TABLE 7 NORTH AMERICA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING

2015-2023 (USD MILLION)

TABLE 8 NORTH AMERICA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG

2015-2023 (USD MILLION)

TABLE 9 NORTH AMERICA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2015-2023 (USD MILLION)

TABLE 10 US IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2015-2023 (USD MILLION)

TABLE 11 US IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG 2015-2023 (USD MILLION)

TABLE 12 US IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2015-2023 (USD MILLION)

TABLE 13 CANADA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2015-2023 (USD MILLION)

TABLE 14 CANADA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG 2015-2023 (USD MILLION)

TABLE 15 CANADA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2015-2023 (USD MILLION)

TABLE 16 SOUTH AMERICA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING

2015-2023 (USD MILLION)

TABLE 17 SOUTH AMERICA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG

2015-2023 (USD MILLION)

TABLE 18 SOUTH AMERICA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2015-2023 (USD MILLION)

TABLE 19 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY 2015-2023 (USD MILLION)

TABLE 20 EUROPE IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2015-2023 (USD MILLION)

TABLE 21 EUROPE IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG 2015-2023 (USD MILLION)

TABLE 22 EUROPE IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2015-2023 (USD MILLION)

TABLE 23 GERMANY IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2015-2023 (USD MILLION)

TABLE 24 GERMANY IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG 2015-2023 (USD MILLION)

TABLE 25 GERMANY IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2015-2023 (USD MILLION)

TABLE 26 U.K TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2015-2023 (USD MILLION)

TABLE 27 U.K TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2015-2023 (USD MILLION)

TABLE 28 U.K TRANSPLANT DIAGNOSTICS MARKET, BY ASSAY & KITS 2015-2023 (USD MILLION)

TABLE 29 FRANCE IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2015-2023 (USD MILLION)

TABLE 30 FRANCE IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG 2015-2023 (USD MILLION)

TABLE 31 FRANCE IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2015-2023 (USD MILLION)

TABLE 32 SPAIN IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2015-2023 (USD MILLION)

TABLE 33 SPAIN IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG 2015-2023 (USD MILLION)

TABLE 34 SPAIN IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2015-2023 (USD MILLION)

TABLE 35 ITALY IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2015-2023 (USD MILLION)

TABLE 36 ITALY IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG 2015-2023

(USD MILLION)

TABLE 37 ITALY IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2015-2023 (USD MILLION)

TABLE 38 REST OF EUROPE IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING

2015-2023 (USD MILLION)

TABLE 39 REST OF EUROPE IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG

2015-2023 (USD MILLION)

TABLE 40 REST OF EUROPE IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2015-2023 (USD MILLION)

TABLE 41 ASIA PACFIC TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY 2015-2023 (USD MILLION)

TABLE 42 ASIA PACIFIC IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2015-2023 (USD MILLION)

TABLE 43 ASIA PACIFIC IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG

2015-2023 (USD MILLION)

TABLE 44 ASIA PACIFIC IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2015-2023 (USD MILLION)

TABLE 45 CHINA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2015-2023 (USD MILLION)

TABLE 46 CHINA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG 2015-2023 (USD MILLION)

TABLE 47 CHINA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2015-2023 (USD MILLION)

TABLE 48 JAPAN IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2015-2023 (USD MILLION)

TABLE 49 JAPAN IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG 2015-2023 (USD MILLION)

TABLE 50 JAPAN IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2015-2023 (USD MILLION)

TABLE 51 INDIA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2015-2023 (USD MILLION)

TABLE 52 INDIA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG 2015-2023 (USD MILLION)

TABLE 53 INDIA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2015-2023 (USD MILLION)

TABLE 54 AUSTRALIA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2015-2023 (USD MILLION)

TABLE 55 AUSTRALIA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG

2015-2023 (USD MILLION)

TABLE 56 AUSTRALIA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2015-2023 (USD MILLION)

TABLE 57 REST OF APAC IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2015-2023 (USD MILLION)

TABLE 58 REST OF APAC IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG

2015-2023 (USD MILLION)

TABLE 59 REST OF APAC IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2015-2023 (USD MILLION)

TABLE 60 MIDDLE EAST & AFRICA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY REGION 2015-2023 (USD MILLION)

TABLE 61 MIDDLE EAST & AFRICA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING

2015-2023 (USD MILLION)

TABLE 62 MIDDLE EAST & AFRICA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG

2015-2023 (USD MILLION)

TABLE 63 MIDDLE EAST & AFRICA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2015-2023 (USD MILLION)

TABLE 64 MIDDLE EAST IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2015-2023 (USD MILLION)

TABLE 65 MIDDLE EAST IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG

2015-2023 (USD MILLION)

TABLE 66 MIDDLE EAST IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2015-2023 (USD MILLION)

TABLE 67 AFRICA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2015-2023 (USD MILLION)

TABLE 68 AFRICA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG 2015-2023 (USD MILLION)

TABLE 69 AFRICA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2015-2023 (USD MILLION)

TABLE 70 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2015-2023 (USD MILLION)

TABLE 71 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2015-2023 (USD MILLION)

TABLE 72 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY ASSAY & KITS 2015-2023 (USD MILLION)

TABLE 73 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2015-2023 (USD MILLION)

TABLE 74 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2015-2023 (USD MILLION)

TABLE 75 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY SEQUENCING-BASED ASSAY 2015-2023 (USD MILLION)

TABLE 76 GLOBAL TRANSPLANT DIAGNOSTICS MARKET FOR INSTRUMENTS, BY REGION 2015-2023 (USD MILLION)

TABLE 77 GLOBAL TRANSPLANT DIAGNOSTICS MARKET FOR REAGENTS & CONSUMABLES, BY REGION 2015-2023 (USD MILLION)

TABLE 78 GLOBAL TRANSPLANT DIAGNOSTICS MARKET FOR SOFTWARE AND SERVICES, BY REGION 2015-2023 (USD MILLION)

TABLE 79 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY SCREENING TYPE 2015-2023 (USD MILLION)

TABLE 80 GLOBAL TRANSPLANT DIAGNOSTICS MARKET FOR PRE-TRANSPLANT SCREENING, BY REGION 2015-2023 (USD MILLION)

TABLE 81 GLOBAL TRANSPLANT DIAGNOSTICS MARKET FOR POST-TRANSPLANT SCREENING, BY REGION 2015-2023 (USD MILLION)

TABLE 82 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY ORGAN TYPE 2015-2023 (USD MILLION)

TABLE 83 GLOBAL TRANSPLANT DIAGNOSTICS MARKET FOR KIDNEY, BY REGION 2015-2023 (USD MILLION)

TABLE 84 GLOBAL TRANSPLANT DIAGNOSTICS MARKET FOR LIVER, BY REGION 2015-2023 (USD MILLION)

TABLE 85 GLOBAL TRANSPLANT DIAGNOSTICS MARKET FOR HEART, BY REGION 2015-2023 (USD MILLION)

TABLE 86 GLOBAL TRANSPLANT DIAGNOSTICS MARKET FOR LUNG, BY REGION 2015-2023 (USD MILLION)

TABLE 87 GLOBAL TRANSPLANT DIAGNOSTICS MARKET FOR PANCREAS, BY REGION 2015-2023 (USD MILLION)

TABLE 88 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 89 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY DIAGNOSTIC APPLICATIONS 2015-2023 (USD MILLION)

TABLE 90 GLOBAL TRANSPLANT DIAGNOSTICS MARKET FOR RESEARCH APPLICATIONS, BY REGION 2015-2023 (USD MILLION)

TABLE 91 GLOBAL TRANSPLANT DIAGNOSTICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION 2015-2023 (USD MILLION)

TABLE 92 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 93 GLOBAL TRANSPLANT DIAGNOSTICS MARKET FOR COMMERCIAL SERVICE PROVIDERS, BY REGION 2015-2023 (USD MILLION)

TABLE 94 GLOBAL TRANSPLANT DIAGNOSTICS MARKET FOR HOSPITALS AND TRANSPLANT CENTERS, BY REGION

2015-2023 (USD MILLION)

TABLE 95 GLOBAL TRANSPLANT DIAGNOSTICS MARKET FOR RESEARCH LABORATORIES AND ACADEMIC INSTITUTES, BY REGION

2015-2023 (USD MILLION)

TABLE 96 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY REGION 2015-2023 (USD MILLION)

TABLE 97 AMERICAS TRANSPLANT DIAGNOSTICS MARKET, BY REGION 2015-2023 (USD MILLION)

TABLE 98 NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY 2015-2023 (USD MILLION)

TABLE 99 NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2015-2023 (USD MILLION)

TABLE 100 NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2015-2023 (USD MILLION)

TABLE 101 NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY ASSAY & KITS 2015-2023 (USD MILLION)

TABLE 102 NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2015-2023 (USD MILLION)

TABLE 103 NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2015-2023 (USD MILLION)

TABLE 104 NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY SEQUENCING-BASED ASSAY 2015-2023 (USD MILLION)

TABLE 105 NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY SCREENING TYPE 2015-2023 (USD MILLION)

TABLE 106 NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY ORGAN TYPE 2015-2023 (USD MILLION)

TABLE 107 NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 108 NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY DIAGNOSTIC APPLICATIONS 2015-2023 (USD MILLION)

TABLE 109 NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 110 U.S. TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2015-2023 (USD MILLION)

TABLE 111 U.S. TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2015-2023 (USD MILLION)

TABLE 112 U.S. TRANSPLANT DIAGNOSTICS MARKET, BY ASSAY & KITS 2015-2023 (USD MILLION)

TABLE 113 U.S. TRANSPLANT DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2015-2023 (USD MILLION)

TABLE 114 U.S. TRANSPLANT DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2015-2023 (USD MILLION)

TABLE 115 U.S. TRANSPLANT DIAGNOSTICS MARKET, BY SEQUENCING-BASED ASSAY 2015-2023 (USD MILLION)

TABLE 116 U.S. TRANSPLANT DIAGNOSTICS MARKET, BY SCREENING TYPE 2015-2023 (USD MILLION)

TABLE 117 U.S. TRANSPLANT DIAGNOSTICS MARKET, BY ORGAN TYPE 2015-2023 (USD MILLION)

TABLE 118 U.S. TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 119 U.S. TRANSPLANT DIAGNOSTICS MARKET, BY DIAGNOSTIC APPLICATIONS 2015-2023 (USD MILLION)

TABLE 120 U.S. TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 121 CANADA TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2015-2023 (USD MILLION)

TABLE 122 CANADA TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2015-2023 (USD MILLION)

TABLE 123 CANADA TRANSPLANT DIAGNOSTICS MARKET, BY ASSAY & KITS 2015-2023 (USD MILLION)

TABLE 124 CANADA TRANSPLANT DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2015-2023 (USD MILLION)

TABLE 125 CANADA TRANSPLANT DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2015-2023 (USD MILLION)

TABLE 126 CANADA TRANSPLANT DIAGNOSTICS MARKET, BY SEQUENCING-BASED ASSAY 2015-2023 (USD MILLION)

TABLE 127 CANADA TRANSPLANT DIAGNOSTICS MARKET, BY SCREENING TYPE 2015-2023 (USD MILLION)

TABLE 128 CANADA TRANSPLANT DIAGNOSTICS MARKET, BY ORGAN TYPE 2015-2023 (USD MILLION)

TABLE 129 CANADA TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 130 CANADA TRANSPLANT DIAGNOSTICS MARKET, BY DIAGNOSTIC APPLICATIONS 2015-2023 (USD MILLION)

TABLE 131 CANADA TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 132 SOUTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2015-2023 (USD MILLION)

TABLE 133 SOUTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2015-2023 (USD MILLION)

TABLE 134 SOUTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY ASSAY & KITS 2015-2023 (USD MILLION)

TABLE 135 SOUTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2015-2023 (USD MILLION)

TABLE 136 SOUTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2015-2023 (USD MILLION)

TABLE 137 SOUTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY SEQUENCING-BASED ASSAY 2015-2023 (USD MILLION)

TABLE 138 SOUTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY SCREENING TYPE 2015-2023 (USD MILLION)

TABLE 139 SOUTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY ORGAN TYPE 2015-2023 (USD MILLION)

TABLE 140 SOUTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 141 SOUTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY DIAGNOSTIC APPLICATIONS 2015-2023 (USD MILLION)

TABLE 142 SOUTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 143 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY 2015-2023 (USD MILLION)

TABLE 144 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2015-2023 (USD MILLION)

TABLE 145 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2015-2023 (USD MILLION)

TABLE 146 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY ASSAY & KITS 2015-2023 (USD MILLION)

TABLE 147 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2015-2023 (USD MILLION)

TABLE 148 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2015-2023 (USD MILLION)

TABLE 149 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY SEQUENCING-BASED ASSAY 2015-2023 (USD MILLION)

TABLE 150 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY SCREENING TYPE 2015-2023 (USD MILLION)

TABLE 151 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY ORGAN TYPE 2015-2023 (USD MILLION)

TABLE 152 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 153 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY DIAGNOSTIC APPLICATIONS 2015-2023 (USD MILLION)

TABLE 154 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 155 GERMANY TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2015-2023 (USD MILLION)

TABLE 156 GERMANY TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2015-2023 (USD MILLION)

TABLE 157 GERMANY TRANSPLANT DIAGNOSTICS MARKET, BY ASSAY & KITS 2015-2023 (USD MILLION)

TABLE 158 GERMANY TRANSPLANT DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2015-2023 (USD MILLION)

TABLE 159 GERMANY TRANSPLANT DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2015-2023 (USD MILLION)

TABLE 160 GERMANY TRANSPLANT DIAGNOSTICS MARKET, BY SEQUENCING-BASED ASSAY 2015-2023 (USD MILLION)

TABLE 161 GERMANY TRANSPLANT DIAGNOSTICS MARKET, BY SCREENING TYPE 2015-2023 (USD MILLION)

TABLE 162 GERMANY TRANSPLANT DIAGNOSTICS MARKET, BY ORGAN TYPE 2015-2023 (USD MILLION)

TABLE 163 GERMANY TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 164 GERMANY TRANSPLANT DIAGNOSTICS MARKET, BY DIAGNOSTIC APPLICATIONS 2015-2023 (USD MILLION)

TABLE 165 GERMANY TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 166 U.K TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2015-2023 (USD MILLION)

TABLE 167 U.K TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2015-2023 (USD MILLION)

TABLE 168 U.K TRANSPLANT DIAGNOSTICS MARKET, BY ASSAY & KITS 2015-2023 (USD MILLION)

TABLE 169 U.K TRANSPLANT DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2015-2023 (USD MILLION)

TABLE 170 U.K TRANSPLANT DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2015-2023 (USD MILLION)

TABLE 171 U.K TRANSPLANT DIAGNOSTICS MARKET, BY SEQUENCING-BASED ASSAY 2015-2023 (USD MILLION)

TABLE 172 U.K TRANSPLANT DIAGNOSTICS MARKET, BY SCREENING TYPE 2015-2023 (USD MILLION)

TABLE 173 U.K TRANSPLANT DIAGNOSTICS MARKET, BY ORGAN TYPE 2015-2023 (USD MILLION)

TABLE 174 U.K TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 175 U.K TRANSPLANT DIAGNOSTICS MARKET, BY DIAGNOSTIC APPLICATIONS 2015-2023 (USD MILLION)

TABLE 176 U.K TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 177 FRANCE TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2015-2023 (USD MILLION)

TABLE 178 FRANCE TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2015-2023 (USD MILLION)

TABLE 179 FRANCE TRANSPLANT DIAGNOSTICS MARKET, BY ASSAY & KITS 2015-2023 (USD MILLION)

TABLE 180 FRANCE TRANSPLANT DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2015-2023 (USD MILLION)

TABLE 181 FRANCE TRANSPLANT DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2015-2023 (USD MILLION)

TABLE 182 FRANCE TRANSPLANT DIAGNOSTICS MARKET, BY SEQUENCING-BASED ASSAY 2015-2023 (USD MILLION)

TABLE 183 FRANCE TRANSPLANT DIAGNOSTICS MARKET, BY SCREENING TYPE 2015-2023 (USD MILLION)

TABLE 184 FRANCE TRANSPLANT DIAGNOSTICS MARKET, BY ORGAN TYPE 2015-2023 (USD MILLION)

TABLE 185 FRANCE TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 186 FRANCE TRANSPLANT DIAGNOSTICS MARKET, BY DIAGNOSTIC APPLICATIONS 2015-2023 (USD MILLION)

TABLE 187 FRANCE TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 188 SPAIN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2015-2023 (USD MILLION)

TABLE 189 SPAIN TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2015-2023 (USD MILLION)

TABLE 190 SPAIN TRANSPLANT DIAGNOSTICS MARKET, BY ASSAY & KITS 2015-2023 (USD MILLION)

TABLE 191 SPAIN TRANSPLANT DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2015-2023 (USD MILLION)

TABLE 192 SPAIN TRANSPLANT DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2015-2023 (USD MILLION)

TABLE 193 SPAIN TRANSPLANT DIAGNOSTICS MARKET, BY SEQUENCING-BASED ASSAY 2015-2023 (USD MILLION)

TABLE 194 SPAIN TRANSPLANT DIAGNOSTICS MARKET, BY SCREENING TYPE 2015-2023 (USD MILLION)

TABLE 195 SPAIN TRANSPLANT DIAGNOSTICS MARKET, BY ORGAN TYPE 2015-2023 (USD MILLION)

TABLE 196 SPAIN TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 197 SPAIN TRANSPLANT DIAGNOSTICS MARKET, BY DIAGNOSTIC APPLICATIONS 2015-2023 (USD MILLION)

TABLE 198 SPAIN TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 199 ITALY TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2015-2023 (USD MILLION)

TABLE 200 ITALY TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2015-2023 (USD MILLION)

TABLE 201 ITALY TRANSPLANT DIAGNOSTICS MARKET, BY ASSAY & KITS 2015-2023 (USD MILLION)

TABLE 202 ITALY TRANSPLANT DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2015-2023 (USD MILLION)

TABLE 203 ITALY TRANSPLANT DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2015-2023 (USD MILLION)

TABLE 204 ITALY TRANSPLANT DIAGNOSTICS MARKET, BY SEQUENCING-BASED ASSAY 2015-2023 (USD MILLION)

TABLE 205 ITALY TRANSPLANT DIAGNOSTICS MARKET, BY SCREENING TYPE 2015-2023 (USD MILLION)

TABLE 206 ITALY TRANSPLANT DIAGNOSTICS MARKET, BY ORGAN TYPE 2015-2023 (USD MILLION)

TABLE 207 ITALY TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 208 ITALY TRANSPLANT DIAGNOSTICS MARKET, BY DIAGNOSTIC APPLICATIONS 2015-2023 (USD MILLION)

TABLE 209 ITALY TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 210 REST OF EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2015-2023 (USD MILLION)

TABLE 211 REST OF EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2015-2023 (USD MILLION)

TABLE 212 REST OF EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY ASSAY & KITS 2015-2023 (USD MILLION)

TABLE 213 REST OF EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2015-2023 (USD MILLION)

TABLE 214 REST OF EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2015-2023 (USD MILLION)

TABLE 215 REST OF EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY SEQUENCING-BASED ASSAY 2015-2023 (USD MILLION)

TABLE 216 REST OF EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY SCREENING TYPE 2015-2023 (USD MILLION)

TABLE 217 REST OF EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY ORGAN TYPE 2015-2023 (USD MILLION)

TABLE 218 REST OF EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 219 REST OF EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY DIAGNOSTIC APPLICATIONS 2015-2023 (USD MILLION)

TABLE 220 REST OF EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 221 ASIA PACFIC TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY 2015-2023 (USD MILLION)

TABLE 222 ASIA PACIFIC TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2015-2023 (USD MILLION)

TABLE 223 ASIA PACIFIC TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2015-2023 (USD MILLION)

TABLE 224 ASIA PACIFIC TRANSPLANT DIAGNOSTICS MARKET, BY ASSAY & KITS 2015-2023 (USD MILLION)

TABLE 225 ASIA PACIFIC TRANSPLANT DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2015-2023 (USD MILLION)

TABLE 226 ASIA PACIFIC TRANSPLANT DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2015-2023 (USD MILLION)

TABLE 227 ASIA PACIFIC TRANSPLANT DIAGNOSTICS MARKET, BY SEQUENCING-BASED ASSAY 2015-2023 (USD MILLION)

TABLE 228 ASIA PACIFIC TRANSPLANT DIAGNOSTICS MARKET, BY SCREENING TYPE 2015-2023 (USD MILLION)

TABLE 229 ASIA PACIFIC TRANSPLANT DIAGNOSTICS MARKET, BY ORGAN TYPE 2015-2023 (USD MILLION)

TABLE 230 ASIA PACIFIC TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 231 ASIA PACIFIC TRANSPLANT DIAGNOSTICS MARKET, BY DIAGNOSTIC APPLICATIONS 2015-2023 (USD MILLION)

TABLE 232 ASIA PACIFIC TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 233 CHINA TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2015-2023 (USD MILLION)

TABLE 234 CHINA TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2015-2023 (USD MILLION)

TABLE 235 CHINA TRANSPLANT DIAGNOSTICS MARKET, BY ASSAY & KITS 2015-2023 (USD MILLION)

TABLE 236 CHINA TRANSPLANT DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2015-2023 (USD MILLION)

TABLE 237 CHINA TRANSPLANT DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2015-2023 (USD MILLION)

"Single User License: OnIine PDF View Only
Enterprise-user License : Print & download option is available."

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS


Companies

Thermo Fisher Scientific Inc.

Bio-Rad Laboratories, Inc.

F. Hoffmann-La Roche AG

Qiagen N.V.

BioMerieux SA

Illumina, Inc.

Becton, Dickinson and Company

Caredx, Inc.

Gendx

Zimmer Biomet

Medtronic PLC

DiaSorin S.P.A

Merck KGaA

Immucor, Inc.